34 research outputs found

    Derivatisasi Morfin Menggunakan Dansil Klorida untuk Meningkatkan Kepekaan Deteksi Morfin pada Metode Klt- Spektrofotodensitometer

    Full text link
    Fluorescence detection could be used for enhance the sensitivity of morphine detection by TLC-Spectrophotodensytometry. Morfin is a compound that fluoresces intrinsically incapable. ence, morphine was derivatized using dansyl chloride. Morphine was derivatized by two methods, derivatization in solution and overspotting method. The derivatization reaction was kept at pH 9 and 450 C for 20 minute. The ratio between dansyl chloride and analyte concentration was 6:1. The derivatization result was separated from the interference using TLC. The TLC method was using Al-TLC silica G60 plate as a stationary phase and etyl acetate : methanol : amonia (85:10:5) as the mobile phase. The dansyl derivative was detected at ?eks 365 nm and K540 filter for fluoresence. Derivatization of morphine-dansyl chloride capable to enhancing the sensitivity of morphine detection using TLC-Spectrophotodensytometry. Derivatization in solution and overspotting method took the same time in procedure but they gave different sensitivity. Derivatization in solution method gave more quantity than derivatization of overspotting

    Mathematical Modelling of Alkaline and Ionic Liquid Pretreated Coconut Husk Enzymatic Hydrolysis

    Get PDF
    The problem of crude oil reserve shortage and air quality decline currently have led researches on renewable fuel such as bioethanol and biohydrogen. The attempt to provide such biofuel involves the utilization of enormously available wasted materials, lignocellulose. Coconut husk is one of such materials available in Indonesia. The previous work had reported the quantity of total reducing sugar produced after the enzymatic hydrolysis of pretreated coconut husk. The pretreatment methods used were dilute sodium hydroxide solution (1 and 4% w/v), 1,3-methylmethylimidazolium dimethyl phosphate ionic liquid and the combination of both methods. This work focused on constructing the mathematical model which describes the kinetic of those enzymatic hydrolysis reactions. Mathematical model expressions help describing as well as predicting the process behavior, which is commonly needed in the process design and control. The development of mathematical model in this work was done based on the total reducing sugar concentration resulted in batch hydrolysis reaction. The kinetic parameters including initial available substrate (S0), maximum reaction rate (rmax), and half-maximum rate constant (KM). According to the values of half-maximum rate constant (KM), the enzymatic hydrolysis performance of coconut husk treated using ionic liquid is better than that treated using dilute alkaline solution as the former had shown lower KM value and hence higher enzyme affinity to the substrate. The best hydrolysis result was performed using combination of 1% dilute sodium hydroxide solution and ionic liquid with kinetic model parameter of 0.5524 g/L.h of rmax, 0.0409 g/L of KM, and 4.1919 g/L of S0. Copyright © 2021 by Authors, Published by BCREC Group. This is an open access article under the CC BY-SA License (https://creativecommons.org/licenses/by-sa/4.0).

    Instalasi Mesin Pengering Gabah 1PK untuk Mendukung Ketahanan Pangan di Kalurahan Sriharjo, Imogiri, Bantul, Yogyakarta

    Get PDF
    Pengeringan gabah secara tradisional dilakukan dengan menjemur di bawah sinar matahari, memerlukan lahan yang luas, dan tergantung cuaca. Untuk mengurangan kendala lahan dan ketergantungan terhadap cuaca, maka diperlukan inovasi sistem pengering buatan. Pada kegiatan pengabdian ini diterapkan sistem pengering menggunakan siklus konversi uap yang mampu mengeringkan gabah dengan mengurangi tingkat kelembaban udara. Sistem pengering yang dihasilkan mampu mengurangi waktu pengeringan dari yang sebelumnya memerlukan waktu 3 - 4  hari menjadi kurang dari 1 hari, mengatasi ketergantungan cuaca, dan dapat dilakukan pada lahan/ruang yang terbatas

    Clinical complexity and impact of the ABC (Atrial fibrillation Better Care) pathway in patients with atrial fibrillation: a report from the ESC-EHRA EURObservational Research Programme in AF General Long-Term Registry

    Get PDF
    Background: Clinical complexity is increasingly prevalent among patients with atrial fibrillation (AF). The ‘Atrial fibrillation Better Care’ (ABC) pathway approach has been proposed to streamline a more holistic and integrated approach to AF care; however, there are limited data on its usefulness among clinically complex patients. We aim to determine the impact of ABC pathway in a contemporary cohort of clinically complex AF patients. Methods: From the ESC-EHRA EORP-AF General Long-Term Registry, we analysed clinically complex AF patients, defined as the presence of frailty, multimorbidity and/or polypharmacy. A K-medoids cluster analysis was performed to identify different groups of clinical complexity. The impact of an ABC-adherent approach on major outcomes was analysed through Cox-regression analyses and delay of event (DoE) analyses. Results: Among 9966 AF patients included, 8289 (83.1%) were clinically complex. Adherence to the ABC pathway in the clinically complex group reduced the risk of all-cause death (adjusted HR [aHR]: 0.72, 95%CI 0.58–0.91), major adverse cardiovascular events (MACEs; aHR: 0.68, 95%CI 0.52–0.87) and composite outcome (aHR: 0.70, 95%CI: 0.58–0.85). Adherence to the ABC pathway was associated with a significant reduction in the risk of death (aHR: 0.74, 95%CI 0.56–0.98) and composite outcome (aHR: 0.76, 95%CI 0.60–0.96) also in the high-complexity cluster; similar trends were observed for MACEs. In DoE analyses, an ABC-adherent approach resulted in significant gains in event-free survival for all the outcomes investigated in clinically complex patients. Based on absolute risk reduction at 1 year of follow-up, the number needed to treat for ABC pathway adherence was 24 for all-cause death, 31 for MACEs and 20 for the composite outcome. Conclusions: An ABC-adherent approach reduces the risk of major outcomes in clinically complex AF patients. Ensuring adherence to the ABC pathway is essential to improve clinical outcomes among clinically complex AF patients

    Impact of renal impairment on atrial fibrillation: ESC-EHRA EORP-AF Long-Term General Registry

    Get PDF
    Background: Atrial fibrillation (AF) and renal impairment share a bidirectional relationship with important pathophysiological interactions. We evaluated the impact of renal impairment in a contemporary cohort of patients with AF. Methods: We utilised the ESC-EHRA EORP-AF Long-Term General Registry. Outcomes were analysed according to renal function by CKD-EPI equation. The primary endpoint was a composite of thromboembolism, major bleeding, acute coronary syndrome and all-cause death. Secondary endpoints were each of these separately including ischaemic stroke, haemorrhagic event, intracranial haemorrhage, cardiovascular death and hospital admission. Results: A total of 9306 patients were included. The distribution of patients with no, mild, moderate and severe renal impairment at baseline were 16.9%, 49.3%, 30% and 3.8%, respectively. AF patients with impaired renal function were older, more likely to be females, had worse cardiac imaging parameters and multiple comorbidities. Among patients with an indication for anticoagulation, prescription of these agents was reduced in those with severe renal impairment, p <.001. Over 24 months, impaired renal function was associated with significantly greater incidence of the primary composite outcome and all secondary outcomes. Multivariable Cox regression analysis demonstrated an inverse relationship between eGFR and the primary outcome (HR 1.07 [95% CI, 1.01–1.14] per 10 ml/min/1.73 m2 decrease), that was most notable in patients with eGFR <30 ml/min/1.73 m2 (HR 2.21 [95% CI, 1.23–3.99] compared to eGFR ≥90 ml/min/1.73 m2). Conclusion: A significant proportion of patients with AF suffer from concomitant renal impairment which impacts their overall management. Furthermore, renal impairment is an independent predictor of major adverse events including thromboembolism, major bleeding, acute coronary syndrome and all-cause death in patients with AF

    Impact of clinical phenotypes on management and outcomes in European atrial fibrillation patients: a report from the ESC-EHRA EURObservational Research Programme in AF (EORP-AF) General Long-Term Registry

    Get PDF
    Background: Epidemiological studies in atrial fibrillation (AF) illustrate that clinical complexity increase the risk of major adverse outcomes. We aimed to describe European AF patients\u2019 clinical phenotypes and analyse the differential clinical course. Methods: We performed a hierarchical cluster analysis based on Ward\u2019s Method and Squared Euclidean Distance using 22 clinical binary variables, identifying the optimal number of clusters. We investigated differences in clinical management, use of healthcare resources and outcomes in a cohort of European AF patients from a Europe-wide observational registry. Results: A total of 9363 were available for this analysis. We identified three clusters: Cluster 1 (n = 3634; 38.8%) characterized by older patients and prevalent non-cardiac comorbidities; Cluster 2 (n = 2774; 29.6%) characterized by younger patients with low prevalence of comorbidities; Cluster 3 (n = 2955;31.6%) characterized by patients\u2019 prevalent cardiovascular risk factors/comorbidities. Over a mean follow-up of 22.5 months, Cluster 3 had the highest rate of cardiovascular events, all-cause death, and the composite outcome (combining the previous two) compared to Cluster 1 and Cluster 2 (all P <.001). An adjusted Cox regression showed that compared to Cluster 2, Cluster 3 (hazard ratio (HR) 2.87, 95% confidence interval (CI) 2.27\u20133.62; HR 3.42, 95%CI 2.72\u20134.31; HR 2.79, 95%CI 2.32\u20133.35), and Cluster 1 (HR 1.88, 95%CI 1.48\u20132.38; HR 2.50, 95%CI 1.98\u20133.15; HR 2.09, 95%CI 1.74\u20132.51) reported a higher risk for the three outcomes respectively. Conclusions: In European AF patients, three main clusters were identified, differentiated by differential presence of comorbidities. Both non-cardiac and cardiac comorbidities clusters were found to be associated with an increased risk of major adverse outcomes
    corecore